Clinical Trial Update: A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate how PF-00299804 affects the pharmacokinetics of dextromethorphan in cancer patients. The trial is completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-00299804

Snippet

Sponsor: Pfizer | Conditions: Advanced Malignant Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2017-08-02